期刊文献+

慢性阻塞性肺疾病急性发作期联合、动态测定CRP和PCT的意义 被引量:2

The Significance of Combined, Dynamic Detection of CRP and PCT in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病急性发作期(AECOPD)患者的C反应蛋白(CRP)和降钙素原(PCT)的动态变化。方法采取前瞻性、连续观察性方法,测定80例AECOPD患者入院第0、24、48小时的CRP和PCT(分别记录为CRP0、CRP1、CRP2和PCT0、PCT1、PCT2),分析CRP、PCT和死亡、住院天数之间的关系。结果 CRP、PCT水平和AECOPD患者住院天数、死亡有正相关关系,CRP1和住院天数相关性最高,PCT1和死亡相关性最高。结论联合、动态测定CRP和PCT,可以早期发现、早期治疗AECOPD患者的细菌感染,及时调整抗感染方案,判断疾病严重程度和预后。 Objective To investigate the dynamic changes of C-reactive protein(CRP) and procalcitonin(PCT) in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods With the prospective continuous observation method, the concentrations of CRP and PCT of 80 AECOPD patients on the adoptions of the 0 hour, the 24 thhour, and the 48thhour(recorded as CRP〈0,CRP1, CRP2 and PCT0, PCT1, PCT2, respectively) were detected. And then the relationships between CRP, PCT and death, days of stay-in-hospital were analyzed. Results There were positive co-relationships between the CRP, PCT levels and death, days of stay-in-hospital. The co-relationship between CRP1 and days of stay-in-hospital was the highest, the co-relationship between PCT1 and death was the highest. Conclusions It is the combined, dynamic detections of CRP and PCT that could help to find out and treat the bacteria infection earlier in patients with acute exacerbation of chronic obstructive pulmonary disease, to adjust the anti-infection program, and to judge the severity of the disease and prognosis.
出处 《临床医学工程》 2015年第6期728-730,共3页 Clinical Medicine & Engineering
关键词 C反应蛋白 降钙素原 慢性阻塞性肺疾病急性发作期 C-reactive protein Procalcitonin Acute exacerbation of chronic obstructive pulmonary disease
  • 相关文献

参考文献9

  • 1Vestbo J,Hurd SS,Agusti AG,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2013,187(4):347-365.
  • 2Sridharan P,Chamberlain RS.The efficacy of procalci tonin as a biomarker in the management of sepsis:slaying dragons or tilting at windmills?[J].Surg Infect(Larchmt),2013,14(6):489-511.
  • 3Riedel S,Carroll KC.Laboratory detection of sepsis:biomarkers and molecular approaches[J].Clin Lab Med,2013,33(3):413-437.
  • 4Gaini S,Koldkjaer OG,Pedersen C,et al.Procalci tonin,lipopolysac charide-binding protein,interleukin-6 and C-reactive protein in com muni ty-acquired infections and sepsis:a prospective study[J].Crit Care,2006,10(2):R53.
  • 5Bloos F,Reinhart K,Rapid diagnosis of sepsis[J].Virulence,2014,5(1):154-160.
  • 6Limper M,de Kruif MD,Duits AJ,et al.The diagnostic role of procal citonin and other biomarkers in discriminating infectious from non-in fectious fever[J].J Infect,2010,60(6):409-416.
  • 7Chazan R.Contemporary clinical diagnostics of respiratory tract infections[J].Pol Merkur Lekarski,2011,30(179):316-319.
  • 8Sridharan P,Chamberlain RS.The efficacy of procalcitonin as a biomarker in the management of sepsis:slaying dragons or tilting at windmills[J].Surg Infect(Larchmt),2013,14(6):489-511.
  • 9Porfyridis I,Georgiadis G,Vogazianos P,et al.C-reac tive protein,procalcitonin,clinical pulmonary infection score,and pneumonia severity scores in nursing home acquired pneumonia[J].Respir Care,2014,59(4):574-581.

同被引文献11

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部